Jiangsu Aoyang Health Industry Co.ltd. (SHE:002172)
China · Delayed Price · Currency is CNY 4.380
-0.390 (-8.18%)
Sep 11, 2026, 10:15 AM CST
SHE:002172 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,653 | 3,040 | 2,397 | 2,902 | 3,162 | 3,086 | |
Market Cap Growth | 10.93% | 26.84% | -17.41% | -8.23% | 2.48% | 34.78% |
Enterprise Value | 4,148 | 3,356 | 2,969 | 3,488 | 3,638 | 4,487 |
Last Close Price | 4.77 | 3.97 | 3.13 | 3.79 | 4.13 | 4.03 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 117.37 | 73.62 | 59.09 | 58.41 | - | - |
Forward PE | - | 16.05 | 16.05 | 16.05 | 16.05 | 16.05 |
PS Ratio | 2.12 | 1.68 | 1.19 | 1.34 | 1.57 | 2.16 |
PB Ratio | 20.13 | 19.32 | 20.80 | 38.80 | 118.02 | 60.70 |
P/TBV Ratio | 27.47 | 28.52 | 39.46 | 167.94 | - | - |
P/OCF Ratio | 203.17 | 240.88 | 5463.93 | 53.44 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.40 | 1.86 | 1.48 | 1.61 | 1.80 | 3.14 |
EV/EBITDA Ratio | 35.86 | 24.83 | 20.46 | 23.28 | 19.86 | 22.46 |
EV/EBIT Ratio | 68.74 | 40.48 | 33.94 | 40.76 | 31.59 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 5.14 | 5.59 | 8.70 | 16.30 | 54.68 | 42.87 |
Debt / EBITDA Ratio | 8.05 | 6.17 | 6.47 | 7.72 | 7.66 | 10.51 |
Net Debt / Equity Ratio | 2.83 | 3.02 | 4.17 | 6.84 | 17.96 | 22.50 |
Net Debt / EBITDA Ratio | 4.59 | 3.51 | 3.31 | 3.42 | 2.63 | 5.72 |
Net Debt / FCF Ratio | -95.52 | -23.76 | -17.05 | -55.08 | -2.12 | -4.49 |
Asset Turnover | 0.92 | 0.94 | 0.94 | 0.88 | 0.62 | 0.28 |
Inventory Turnover | 11.77 | 11.03 | 10.49 | 10.50 | 10.24 | 4.58 |
Quick Ratio | 0.53 | 0.51 | 0.55 | 0.54 | 0.64 | 0.74 |
Current Ratio | 0.62 | 0.61 | 0.65 | 0.65 | 0.72 | 0.80 |
Return on Equity (ROE) | 20.79% | 30.73% | 43.40% | 98.94% | -40.50% | -162.50% |
Return on Assets (ROA) | 2.01% | 2.70% | 2.55% | 2.16% | 2.20% | -0.17% |
Return on Invested Capital (ROIC) | 6.41% | 9.48% | 9.36% | 11.24% | 13.53% | -0.80% |
Return on Capital Employed (ROCE) | 24.40% | 32.90% | 26.90% | 43.90% | 55.50% | -3.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.93% | 1.36% | 1.69% | 1.71% | -0.49% | -33.67% |
FCF Yield | -0.15% | -0.66% | -1.18% | -0.32% | -7.18% | -8.25% |
Payout Ratio | 79.66% | 68.99% | 80.50% | 69.57% | - | - |
Buyback Yield / Dilution | -0.21% | -1.80% | 2.03% | -7.78% | 0.91% | 0.34% |